
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17336371
[patent_doc_number] => 20220002702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/447372
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447372
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/447372 | FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION | Sep 9, 2021 | Abandoned |
Array
(
[id] => 18717867
[patent_doc_number] => 11795198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof
[patent_app_type] => utility
[patent_app_number] => 17/465727
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 43
[patent_no_of_words] => 22253
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465727 | Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof | Sep 1, 2021 | Issued |
Array
(
[id] => 17443714
[patent_doc_number] => 20220064219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Antimicrobial And Antibiofilm Peptides Sequences With Metal-Binding Motifs
[patent_app_type] => utility
[patent_app_number] => 17/446102
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17446102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/446102 | Antimicrobial And Antibiofilm Peptides Sequences With Metal-Binding Motifs | Aug 25, 2021 | Abandoned |
Array
(
[id] => 18792697
[patent_doc_number] => 11826431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Polypeptide-based ocular absorption enhancer and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/410174
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 6994
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410174
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410174 | Polypeptide-based ocular absorption enhancer and application thereof | Aug 23, 2021 | Issued |
Array
(
[id] => 17398281
[patent_doc_number] => 20220040371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => PHOTOACTIVATED CROSSLINKING OF A PROTEIN OR PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/408582
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408582
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/408582 | PHOTOACTIVATED CROSSLINKING OF A PROTEIN OR PEPTIDE | Aug 22, 2021 | Pending |
Array
(
[id] => 18895197
[patent_doc_number] => 20240010682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => HEMOSTATIC ELASTIN-LIKE POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/042001
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042001 | HEMOSTATIC ELASTIN-LIKE POLYPEPTIDES | Aug 16, 2021 | Pending |
Array
(
[id] => 17299488
[patent_doc_number] => 20210395327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Growth Hormone-Releasing Hormone Antagonists and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/396304
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396304 | Growth Hormone-Releasing Hormone Antagonists and Uses Thereof | Aug 5, 2021 | Pending |
Array
(
[id] => 17399570
[patent_doc_number] => 20220041660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => COMPOSITIONS AND METHODS FOR SEQUESTERING VIRAL PARTICLES IN RESPIRATORY TRACT
[patent_app_type] => utility
[patent_app_number] => 17/396006
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/396006 | COMPOSITIONS AND METHODS FOR SEQUESTERING VIRAL PARTICLES IN RESPIRATORY TRACT | Aug 5, 2021 | Abandoned |
Array
(
[id] => 18620425
[patent_doc_number] => 11753453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Peptide kinase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/394431
[patent_app_country] => US
[patent_app_date] => 2021-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 23
[patent_no_of_words] => 11593
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394431
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/394431 | Peptide kinase inhibitors and methods of use thereof | Aug 4, 2021 | Issued |
Array
(
[id] => 17385592
[patent_doc_number] => 20220033444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Cyclic Peptides, Methods of Synthesis, and Methods of Treatment
[patent_app_type] => utility
[patent_app_number] => 17/390383
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390383 | Cyclic peptides, methods of synthesis, and methods of treatment | Jul 29, 2021 | Issued |
Array
(
[id] => 17427000
[patent_doc_number] => 20220054708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => FUNCTIONALIZATION OF PLANT TISSUES FOR HUMAN CELL EXPANSION
[patent_app_type] => utility
[patent_app_number] => 17/388652
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17388652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/388652 | Functionalization of plant tissues for human cell expansion | Jul 28, 2021 | Issued |
Array
(
[id] => 18647856
[patent_doc_number] => 20230293632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/017669
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017669 | USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS | Jul 25, 2021 | Pending |
Array
(
[id] => 17227269
[patent_doc_number] => 20210353825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => SCALABLE THREE-DIMENSIONAL ELASTIC CONSTRUCT MANUFACTURING
[patent_app_type] => utility
[patent_app_number] => 17/385862
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/385862 | SCALABLE THREE-DIMENSIONAL ELASTIC CONSTRUCT MANUFACTURING | Jul 25, 2021 | Abandoned |
Array
(
[id] => 17657073
[patent_doc_number] => 20220177538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/383192
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383192 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | Jul 21, 2021 | Abandoned |
Array
(
[id] => 18345957
[patent_doc_number] => 20230134067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => A PEPTIDE USED FOR IMMUNOTHERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/639547
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639547 | A PEPTIDE USED FOR IMMUNOTHERAPEUTICS | Jul 20, 2021 | Abandoned |
Array
(
[id] => 17343665
[patent_doc_number] => 20220009996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => CELL SURFACE MODIFICATION BY COATING WITH PEPTIDE AMPHIPHILES (PAS)
[patent_app_type] => utility
[patent_app_number] => 17/373977
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373977
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373977 | Cell surface modification by coating with peptide amphiphiles (PAs) | Jul 12, 2021 | Issued |
Array
(
[id] => 19003605
[patent_doc_number] => 20240067676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => POLYPEPTIDE HAVING ANTI-AGING ACTIVITY, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/767403
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767403 | Polypeptide having anti-aging activity, and application thereof | Jul 1, 2021 | Issued |
Array
(
[id] => 17368338
[patent_doc_number] => 20220023390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/365443
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365443 | METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS | Jun 30, 2021 | Abandoned |
Array
(
[id] => 18649423
[patent_doc_number] => 20230295233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/013344
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013344
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013344 | Polypeptide for repairing mucosal damage or skin wound and use thereof | Jun 30, 2021 | Issued |
Array
(
[id] => 18649425
[patent_doc_number] => 20230295235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COMPOUNDS TARGETING ALPHA4-BETA7 INTEGRIN
[patent_app_type] => utility
[patent_app_number] => 18/011997
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011997 | COMPOUNDS TARGETING ALPHA4-BETA7 INTEGRIN | Jun 24, 2021 | Pending |